Lb Pharmaceuticals (LBRX) Change in Acquisitions & Divestments (2024 - 2026)
Lb Pharmaceuticals (LBRX) posted quarterly Change in Acquisitions & Divestments of $2.5 million for Q1 2025, down 61.6% quarter-over-quarter from $6.5 million in Q4 2024.
Powered by 
Analysis
Lb Pharmaceuticals (LBRX) Change in Acquisitions & Divestments (2024 - 2026) Analysis & Trends
Lb Pharmaceuticals' Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $2.5 million for Q1 2025.
- In Q1 2025, Change in Acquisitions & Divestments changed N/A year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $9.0 million (changed N/A YoY), while the FY2025 annual figure was $2.5 million, down 89.43% from the prior year.
- Change in Acquisitions & Divestments for Q1 2025 stood at $2.5 million, down from $6.5 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $6.5 million in Q4 2024, with the low at $2.5 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Lb Pharmaceuticals | 1.49 Bn | 1.49 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.20 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | 7.27 Mn |